Registration No. EC/NEW/INST/2020/531 Approval date: 12-Mar-2020 for two years.

ETHICS COMMITTEE REGISTERED WITH Central Drugs Standard Control Organisation Directorate General Of Health Services Ministry of Health &Family Welfare, Government of India

Registration of Ethics Committee Relating to Clinical Trial or Bioavailability and Bioequivalnence Study

Ethics Committee Registration No. ECR/1361/Inst/PB/2020 issued under New Drugs and Clinical Trials Rules, 2019. Approval Date: 20-Mar-2020

Contact Us

Dr. Thakur Gurjeet Singh
Member Secretary, IHEC
Chitkara University, Punjab
IHEC Coordinator
Dr. Ravinder Singh

Chitkara University Research and Innovation Network (CURIN)
Chitkara University, Punjab Campus, Chandigarh-Patiala National Highway, Rajpura-140401

Basic Responsibilities

Chitkara University defines anINTO Institutional Human Ethical Committee (CU.IHEC ) as a group formally designated to protect the rights, safety and well-being of humans involved in a clinical trial by reviewing all aspects of the trial and approving its startup.

An IHEC reviews the appropriateness of the clinical trial protocol as well as the risks and benefits to study participants. It ensures that clinical trial participants are exposed to minimal risks in relation to any benefits that might result from the research.


  • Reviews all study-related materials before and during the trial
  • Must operate in accordance with national and/or local regulations of Indian Council of Medical Research

IHEC Responsibilities Before, During and After a Research Study

Before any research is allowed to start enrolling human subjects, the IHEC must review all study-related materials in an initial review. The IHEC also performs periodic reviews – called continuing reviews – throughout the study. Continuing reviews may take place at least once a year and include the entire study, not just changes.

The IHEC may also ask for additional information regarding payments and compensation to study participants, as well as the informed consent process.

Investigator Responsibilities for Ensuring Compliance

The principal investigator (PI) or Supervisors are responsible for ensuring compliance with any IHEC procedures or requirements. He or she may deviate from the study protocol without prior IHEC approval only to eliminate immediate safety hazard to a study participant. In addition, the PI must notify the IHEC of any departures from the protocol as soon as possible.

Scheduled IHEC Meeting

  • March, 2021

Form Submission Deadline

  • 20 February, 2021

For form submission, PI/Supervisor/researchers shall be responsible to check the submission dates and deadlines updated on IHEC home page and submit the form timely.
No personal requests shall be entertained.